IFNA1 and viral infectious disease: While numbers are very limited, it is of interest that all three, including the two other patients with biallelic RNASEH2B variants, had completely asymptomatic “silent” COVID-19 infections possibly suggesting a protective effect of IFN upregulation in the setting of viral infection.